77 related articles for article (PubMed ID: 25028400)
21. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
Garrison JB; Samuel T; Reed JC
Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
[TBL] [Abstract][Full Text] [Related]
22. Regulation of pro-inflammatory signalling networks by ubiquitin: identification of novel targets for anti-inflammatory drugs.
Evans PC
Expert Rev Mol Med; 2005 Jun; 7(12):1-19. PubMed ID: 15967057
[TBL] [Abstract][Full Text] [Related]
23. Analysis of NF-kappaB signaling pathways by proteomic approaches.
Niederberger E; Geisslinger G
Expert Rev Proteomics; 2010 Apr; 7(2):189-203. PubMed ID: 20377387
[TBL] [Abstract][Full Text] [Related]
24. Vagal stimulation triggers peripheral vascular protection through the cholinergic anti-inflammatory pathway in a rat model of myocardial ischemia/reperfusion.
Zhao M; He X; Bi XY; Yu XJ; Gil Wier W; Zang WJ
Basic Res Cardiol; 2013 May; 108(3):345. PubMed ID: 23519622
[TBL] [Abstract][Full Text] [Related]
25. Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways.
Zeng KW; Wang S; Dong X; Jiang Y; Tu PF
Phytomedicine; 2014 Feb; 21(3):298-306. PubMed ID: 24055519
[TBL] [Abstract][Full Text] [Related]
26. NF-kappaB signaling in lymphocytes: a new cast of characters.
Lucas PC; McAllister-Lucas LM; Nunez G
J Cell Sci; 2004 Jan; 117(Pt 1):31-9. PubMed ID: 14657271
[TBL] [Abstract][Full Text] [Related]
27. Itching to end NF-kappaB.
Heissmeyer V; Rao A
Nat Immunol; 2008 Mar; 9(3):227-9. PubMed ID: 18285770
[No Abstract] [Full Text] [Related]
28. Saikosaponin a, an active compound of Radix Bupleuri, attenuates inflammation in hypertrophied 3T3-L1 adipocytes via ERK/NF-κB signaling pathways.
Kim SO; Park JY; Jeon SY; Yang CH; Kim MR
Int J Mol Med; 2015 Apr; 35(4):1126-32. PubMed ID: 25672367
[TBL] [Abstract][Full Text] [Related]
29. Proteomics and NF-κB: an update.
Niederberger E; Geisslinger G
Expert Rev Proteomics; 2013 Apr; 10(2):189-204. PubMed ID: 23573785
[TBL] [Abstract][Full Text] [Related]
30. Peperomins as anti-inflammatory agents that inhibit the NF-kappaB signaling pathway.
Tsutsui C; Yamada Y; Ando M; Toyama D; Wu JL; Wang L; Taketani S; Kataoka T
Bioorg Med Chem Lett; 2009 Aug; 19(15):4084-7. PubMed ID: 19559609
[TBL] [Abstract][Full Text] [Related]
31. Probes to monitor activity of the paracaspase MALT1.
Hachmann J; Edgington-Mitchell LE; Poreba M; Sanman LE; Drag M; Bogyo M; Salvesen GS
Chem Biol; 2015 Jan; 22(1):139-47. PubMed ID: 25556944
[TBL] [Abstract][Full Text] [Related]
32. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
33. Ubiquitylation within signaling pathways in- and outside of inflammation.
Hochrainer K; Lipp J
Thromb Haemost; 2007 Mar; 97(3):370-7. PubMed ID: 17334503
[TBL] [Abstract][Full Text] [Related]
34. Regulation of NF-kappaB transcriptional activity.
Vermeulen L; Vanden Berghe W; Haegeman G
Cancer Treat Res; 2006; 130():89-102. PubMed ID: 16610704
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effects of benzenediamine derivate FC-98 on sepsis injury in mice via suppression of JNK, NF-κB and IRF3 signaling pathways.
Song Y; Liu X; Yue H; Ji J; Dou H; Hou Y
Mol Immunol; 2015 Oct; 67(2 Pt B):183-92. PubMed ID: 26032013
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.
Viatour P; Merville MP; Bours V; Chariot A
Trends Biochem Sci; 2005 Jan; 30(1):43-52. PubMed ID: 15653325
[TBL] [Abstract][Full Text] [Related]
37. Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells.
Yang Z; Li C; Wang X; Zhai C; Yi Z; Wang L; Liu B; Du B; Wu H; Guo X; Liu M; Li D; Luo J
J Cell Physiol; 2010 Oct; 225(1):266-75. PubMed ID: 20509140
[TBL] [Abstract][Full Text] [Related]
38. [The present state of the theory of inflammation].
ALPERN DE
Dtsch Gesundheitsw; 1953 Mar; 8(10):281-90. PubMed ID: 13067747
[No Abstract] [Full Text] [Related]
39. [Current state of the inflammation problem].
GUNTHER B
Dia Med Urug; 1946; 13(153):268-76. PubMed ID: 20983654
[No Abstract] [Full Text] [Related]
40. Report on the Present State of Our Knowledge of the Nature of Inflammation.
Jones TW
Br Foreign Med Rev; 1844 Apr; 17(34):567-586. PubMed ID: 30162180
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
